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The effectiveness of low trans-fatty acids dietary pattern 
in pregnancy and the risk of gestational diabetes 
mellitus 
 
Abstract 
Background: Gestational diabetes mellitus (GDM) is a common disorder in pregnancy. 
The association of trans fatty acids (TFA) intake and risk of GDM have been reported; It 
remains unclear whether dietary TFA can influence GDM risk. We examined the effect of 
low TFA dietary intakes during pregnancy on risk of GDM. 
Methods: This randomized controlled trial was performed on 800 pregnant women who 
were randomly divided into 393 intervention and 407 comparison groups with gestational 
age ≥7 weeks. In the intervention group, the diet of pregnant women was designed in such 
a way that their daily intake of TFA content was less than1% but in control group, the 
daily intake of TFA content was not changed. The dietary intake was assessed using a 24-
hour dietary recall questionnaire for three non-consecutive days at the beginning of the 
pregnancy before week 7, and at 13, 25 and 35 weeks. Diagnosis of GDM was performed 
using a 3-hour glucose tolerance test with 100 g glucose at 24-28 weeks of gestation. 
Results: 14 women in the intervention group (5%) and 31 women in the control group 
(8%) were diagnosed with GDM. Chi-square test did not show any significant difference 
between two groups (P=0.08). Cox model was used and the variables were examined in 
four multivariate models that none of the modals showed a statistically significant 
difference between the two groups regarding the incidence of GDM. 
Conclusion: It seems that the diet with low trans-fatty acid content has no effect on the 
incidence of GDM. 
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Gestational diabetes is one of the adverse effects of pregnancy that is diagnosed with 
increased blood sugar in pregnant women, for the first time, during pregnancy (1, 2). Many 
risk factors are involved in this disease incidence, and in recent decades, many attempts 
have been made to identify further risk factors to prevent gestational diabetes (3, 4). One 
risk factor that has recently been taken into consideration is mothers’ diet during 
pregnancy (5). A component of diet that can affect glucose homeostasis and insulin action 
in mothers is the trans-fatty acids in the mother's diet (6). In a study conducted by Radesky 
et al. in 2008, it was stated that the consumption of trans-fatty acids increased the risk of 
developing gestational diabetes (7).  
In 2011, Ley et al. showed that reduced consumption of unsaturated fatty acids and 
increased intake of trans-fatty acids intensifies the risk of developing gestational diabetes 
(8). However, Bowers et al., stated that the use of trans-fatty acids does not affect insulin 
and glucose homeostasis (9). 
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Despite the inconsistencies in the results of studies, so far 
no study has been done in Iran to evaluate the effect of trans-
fatty acids in pregnancy and its effect on gestational diabetes 
mellitus. Hence the researcher attempted to conduct a study 
on the effect of diet with low intake of trans-fatty acid 
content on gestational diabetes mellitus in pregnant women 
who referred to Shahid Beheshti University of Medical 
Sciences in 2014-2017. 
 
 
Methods  
Study Population: This study is a randomized controlled 
trial that was conducted in Tehran from December 2014 to 
February 2017 after approval by ethical committee of Shahid 
Beheshti University of Medical Sciences under the following 
code of practice IR.SBMU.ries.Rec.1394.92 
(IRCT2016092729902N3). In this study, 1016 pregnant 
women that fulfilled the inclusion criteria were registered 
after obtaining written informed consent; they referred to 
Shahid Beheshti University of Medical Sciences for 
receiving prenatal care. The criteria for entering the study 
were: gestational age ≥7 weeks; singleton pregnancy; 
24>BMI>18, age range of 18-35; the number of pregnancy 
was less than 3; abortion less than 2; no history of 
gestational diabetes in previous pregnancies; no history of 
infant Macrosomia; no history of fetal death; no history of 
diabetes in first-degree relatives; no chronic diseases such as 
diabetes and hypertension; no consumption of cigarette, 
alcohol or drugs. During the study, 133 pregnant women 
were excluded from the study because they did not attend the 
health centers, 49 pregnant women were excluded because of 
their reluctance to continue with the study and 54 pregnant 
women were excluded since they did not follow the diet 
designed for them properly. Ultimately, 800 pregnant 
women were studied in the present study. 
In the first appointment with pregnant women, the 
purpose of the study and the method of work were fully 
explained. Then, demographic and midwifery questionnaires 
were filled in for each pregnant woman through an 
interview. The pregnant women were divided into two 
groups of control and intervention by random number tables. 
Data Collection and Evaluation: The pregnant women 
information was collected through face-to-face interview 
using organized questionnaires. The questionnaires consisted 
of three parts. 1. A demographic questionnaire examining the 
age, occupational status and education of pregnant women. 
Information obtained from this questionnaire was important 
because studies have shown that age, employment and 
education status of pregnant women can affect pregnancy 
outcomes such as diabetes (2, 10). 2. Midwifery 
questionnaire that provided information about the gestational 
age at the first appointment, the number of pregnancies, the 
number of abortions, the gestational age at the next referrals, 
the pre-pregnancy BMI, fasting blood glucose, fasting blood 
glucose at gestational age of 24-28 weeks; and one, two, and 
three hours after receiving 100 grams of glucose syrup. 3. A 
24-hour dietary recall questionnaire assessed dietary 
information of pregnant women. The questionnaire includes 
breakfast, snack, lunch, snack, dinner, and snack before 
bedtime, and examines the details of pregnant women’s diet 
during the last 24 hours. The questionnaire was filled in 
through interviews in four stages at the beginning of 
pregnancy (before intervention and less than 7 weeks), 13 
weeks, 25 weeks and 35 weeks of gestation in three non-
consecutive days (one non-working day and two working 
days). The first dietary recall questionnaire was filled 
through interviews at the health center, and it usually lasted 
from 20 to 30 minutes, and subsequent questionnaires was 
filled through phone conversation. Each interview lasted 
about 20 minutes. The pregnant women were asked about the 
daily food items in detail, and then the details were 
transferred to gram and entered the questionnaire. The 
interviews were conducted by five nutritionists; and a 
midwife supervised the performance of the group. Prior to 
study conduction, all interviewers received training for three 
days on how to conduct interviews and complete the 24-hour 
dietary questionnaire, how to collect nutritional information 
and how to complete the other questionnaires. 
Nutrition Intervention: For all pregnant women who 
participated in the study, a unique daily diet was designed 
based on their age, height, pre-pregnancy weight and daily 
physical activity. 
To reduce trans-fatty acids to less than 1% of total daily 
energy intake of pregnant women in the intervention group, a 
food basket was provided for pregnant women including 
olive oil for cooking, 0% dairy products and nuts for the 
necessary fat content of the diet. The consumption of any 
kind of fast foods, deep-fried foods and processed protein 
products such as sausages and hotdogs was also prohibited 
for pregnant women. For pregnant women, the control group 
also was provided with a food basket containing liquid oil, 
1.5% dairy products, and pregnant women in this group were 
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recommended to refrain from fast foods and deep-fried foods 
and processed protein products. All pregnant women were 
also given an alternative list of foods in addition to the diet 
so that they could replace any item in the designed diet list 
that they were reluctant to use with a similar item on the 
alternative list. The dietary intake of pregnant women was 
evaluated using the US Department of Agriculture and the 
Iranian food composition table (11, 12). All dietary recall 
questionnaires were checked by the researcher and any 
ambiguity was examined and resolved via a proposal of 
question from pregnant women. 
Midwifery Information: The pregnant women in both 
groups received routine nursing care. The gestational age of 
pregnant women was measured from the first day of their 
last menstrual cycle and via medical ultrasound at gestation 
of less than 12 weeks. The pregnant women up to 28 weeks 
received routine pregnancy care monthly, from 28 to 36 
weeks, twice a month, and then up to the end of pregnancy  
they received weekly care. 
Data collection and outcome measures: The primary 
endpoint measure in this trial is glucose dysfunction, which 
will be assessed in terms of mean reduction in fasting plasma 
glucose levels from the time of the baseline assessment to 
the follow-up assessment (24-28 weeks) on a 100 gram oral 
glucose tolerance test. 
Blood glucose of all pregnant women was routinely 
examined at the beginning of pregnancy (in the first visit) 
and then at 24-28 weeks of gestation. Also, all pregnant 
women performed a-three hour glucose tolerance test at 100 
g oral glucose at 28-24 weeks, then their blood glucose was 
examined one, two and three hours after receiving glucose 
syrup, and in the case that fasting blood glucose was more 
than 92, and one hour later, blood glucose was more than 
180 given, and two hours later, it was more than 155, and 
three hours later, it was more than 140mg/dl, there women 
were diagnosed with gestational diabetes. Also, if two of 
these four blood tests were abnormal, the pregnant women 
were diagnosed with gestational diabetes mellitus (figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1: CONSORT follow chart 
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Statistical Analysis: Normality of all variables was 
investigated using Kolmogorov-Smirnov test and histogram 
chart. All of the variables studied were normal. Mean, 
standard deviation and frequency were calculated for all 
variables in both groups. In this study, to test the significance 
level between the two groups, t-test was used for quantitative 
variables and chi-square test was used for qualitative 
variables.  
The repeated measures test was used to evaluate the 
midwifery and nutritional changes during follow up. A 
logistic regression test was used to evaluate the effect of diet 
with trans-fatty acid content less than 1% on gestational 
diabetes mellitus.  
The Cox model was used to evaluate the effect of diet 
with trans-fatty acid content less than 1% over time.  
In this model, the study groups were considered as 
independent variables and gestational diabetes mellitus as 
dependent variable.  
Incidence rate and risk ratio (CI=95%) for gestational 
diabetes were calculated in both groups.  
The multivariate models for the two groups were based 
on age (years) and pre-pregnancy BMI (kg/m
2
) in the first 
model; age, pre-pregnancy BMI and the number of 
pregnancies in the second model; age, pre-pregnancy BMI, 
the number of pregnancies and fasting blood glucose at the 
beginning of gestation in the third model; age, pre-pregnancy 
BMI, the number of pregnancies, fasting blood glucose at 
beginning of gestation and fasting blood glucose at 24-28 
weeks of gestation in the fourth model. The significance 
level was considered P<0.05. 
 
Results  
Among the 1016 pregnant women who participated in 
this study, 113 pregnant women were excluded from the 
study because they refused to attend health centers, 49 
pregnant women were excluded because their husbands were 
reluctant about their participation in the study and 54 
pregnant women were excluded since they did not follow the 
diet designed for them properly. Finally, 800 pregnant 
women in the study were divided into comparison group 
with n=407 pregnant women and intervention group with 
n=393 women. The mean ages of pregnant women were 
2.8±24.5 and the mean of pre-pregnancy BMI in pregnant 
women were 1.6±21.9kg/m
2
 and there was no significant 
difference between the two groups in terms of these two 
variables (P=0.31) and (P=0.34). 67.5% of participants had 
diploma and 67.3% of the pregnant women were housewives 
and there was no significant difference between the two 
groups in terms of these two variables (P=0.82) (table 1). 
Statistical analysis showed that there was no significant 
difference between the two groups in terms of daily intake of 
energy, protein, carbohydrate and fat at the end of each 
quarter of pregnancy, and the two groups were completely 
homogeneous in terms of daily intake of macronutrients 
(P>0.05). There was a significant difference between the 
intervention and comparison groups regarding the daily 
trans-fatty acid intake (P<0.05) (table 2). In the intervention 
group, all pregnant women received less than 1% of the total 
energy intake, trans-fatty acids, while the average daily 
intake of trans-fatty acids by pregnant women in the control 
group was 7% of the total daily energy intake. 
Table1: Baseline characteristics of the all participants via the intervention and control groups 
 
P-value* Intervention 
(n=393) 
Control 
(n=407) 
All 
(n=800) 
 
 
0.31 24.4(2.9) 24.6(2.7) 24.5(2.8) Age(years) 
0.34 22(1.72) 21.9(1.63) 21.9(1.61) Pre pregnancy BMI(Kg/m2) 
0.93 109.7(7.67) 109(7.36) 109.7(7.33) blood pressure<7 weeks 
0.82 272(68) 266(66) 538 (67) House wives occupation n (%) 
0.11 268(67) 272(68) 540(67) High school education n (%) 
0.12 299(76) 302(74) 601(75) Nulli porous (%) 
0.56 330(83) 347(83) 667(83) Para 0 n (%) 
0.23 362(89) 352(89) 714(89.3) Abortion 0 n (%) 
 
Data are presented as mean (standard deviation) for continuous variables and percentage for categorically distributed variables. 
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Table2: Dietary intake of participants of the intervention and control groups 
 Control 
(n=407) 
Intervention 
(n=393) 
P-value 
Energy (kcal) <7weeks 2083±241 2024±207 0.06 
13weeks 2024±61 2015±54 0.08 
25weeks 2352±53 2346±53 0.06 
35weeks 2457±50 2447±52 0.07 
Carbohydrate (%) <7weeks 50±3.81 51±3.21 0.06 
13weeks 53±3.32 55±2.55 0.07 
25weeks 52±3.13 53±2.52 0.06 
35weeks 53±3 54±2.62 0.07 
Protein (%) 
 
<7weeks 13±1.41 12±1.36 0.06 
13weeks 18±1.24 19±1.25 0.08 
25weeks 17±1.23 18±1.26 0.07 
35weeks 17±1.11 18±1.02 0.07 
Total fat (%) 
 
<7weeks 37±10 37±8 0.06 
13weeks 30±6.65 30±6.23 0.08 
25weeks 31±3.12 30±3.24 0.08 
35weeks 30±2.61 29±2.94 0.07 
TFAs (%)  <7weeks 10±2.32 9±1.34 0.07 
 13weeks 8±1.33 1±0.82 0.04 
 25weeks 7±1.15 0.91±0.65 0.03 
 35weeks 7±1.45 0.89±0.60 0.03 
                                                       Data are presented as mean (standard deviation) 
 
Of the 800 pregnant women who participated in the 
study, 45 pregnant women were diagnosed with gestational 
diabetes of which 31 (8%) of them were in the comparison 
group and 14 (5%) others were in the intervention group. 
Chi-square test did not show a significant difference between 
the two groups (P=0.08). With regard to the difference in the 
incidence rate of gestational diabetes in both intervention 
and control groups, and also to investigate the effect of time 
factor in incidence of this adverse effect, Cox model was 
used and the variables were examined in four multivariate 
models that none of the modals showed a statistically 
significant difference between the two groups regarding the 
incidence of gestational diabetes (table 3). The Kaplan Meier 
chart showed that in comparison group, the onset of 
gestational diabetes mellitus in pregnant women occurs at 
gestation of 24 weeks, and in intervention group, it occurs at 
gestation of 30 weeks. In other words, a diet with trans-fatty 
acid content of less than 1% could have delayed the 
incidence of gestational diabetes in the intervention group of 
6 weeks gestation. 95% of women with gestational diabetes 
mellitus were at gestational age of over 32 weeks in the  
 
intervention group; and in control group, only 8% of 
pregnant women with gestational diabetes were at 
gestational age of over 32 weeks, and 92% of them had 
developed gestational diabetes between 24-32 weeks of 
gestation (figure 2); diet with trans-fatty acid content of less 
than 1% increased the gestational age for the incidence of 
gestational diabetes mellitus in the intervention group. 
Table 3: Hazard ratio (95% CI) for developing GDM 
based on dietary pattern ≤1% TFAs intake 
Models Hazard ratios CI (95%) P-value 
Model.1 
Model.2 
Model.3 
Model.4
 
0.60 
0.58 
0.68 
0.92 
0.34-1.05 
0.34-1.01 
0.39- 1.20 
0.51- 1.60 
0.07 
0.06 
0.07 
0.08 
Model.1: group was adjusted. 
Model.2: group, age, pre pregnancy BMI and gravidity were adjusted. 
Model.3: group, age, pre pregnancy BMI, gravidity and first 
trimester fasting blood sugar were adjusted. 
Model.4: group, age, pre pregnancy BMI, gravidity, trimester 
fasting blood sugar and fasting blood sugar at 24-28 week were 
adjusted. 
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Fig 2: Kaplan-Meier plots for GDM in two intervention 
and control groups. 
 
Discussion 
In this randomized controlled trial, the effect of diet with 
trans-fatty acid content of less than 1%, on the risk of 
gestational diabetes mellitus was investigated. The results of 
this study showed that although the incidence rate of 
gestational diabetes in the intervention group was 3% lower 
than in control group, the decrease was not statistically 
significant, moreover, Cox regression model did not show 
any significant difference in risk ratio between intervention 
and control groups (P>0.05).  
The results of this study were consistent with the results 
of the study by Lauszus et al., 2001 (13). In clinical trial 
study conducted by Lauszus et al. in Denmark, there was no 
significant difference in the risk ratio of gestational diabetes 
in pregnant women receiving a diet rich in fatty acids with 
pregnant women receiving a carbohydrate-rich diet. Lauszus 
et al. have stated that trans-fatty acids did not affect the 
probability of developing gestational diabetes and also had 
no effect on the incidence time of gestational diabetes. 
Lauszus et al stated that excessive intake of trans-fatty acids 
may be effective on insulin resistance, but this effect cannot 
lead to gestational diabetes. 
In a clinical trial conducted by Louie et al. on 92 
pregnant women in 2011, the risk of developing gestational 
diabetes in pregnant women receiving fiber-rich diets was 
reduced by 16% in proportion to the pregnant women 
receiving a diet rich in fatty acids and the protein (14). In the 
study of Louie et al., The mean age of gestational diabetes 
incidence in pregnant women that received diet rich in fiber 
was at 33 weeks and in pregnant women that received diet 
rich in fat and protein was at 28 weeks. Louie et al. stated 
that fiber in the diet could improve pancreatic function, 
reduce insulin resistance, and improve glucose homeostasis 
due to high levels of antioxidants. The results of the study by 
Louie et al. are inconsistent with the results of the present 
study. This contradiction can be due to several reasons. First, 
Louie et al. did not place any limitation on pre-pregnancy 
BMI of pregnant women who participated in the study and 
included pregnant women with a pre-pregnancy BMI of over 
25kg/m
2
 as well. Overweight and obesity (BMI more than 
25kg/m
2
) are the known risk factors in gestational diabetes 
mellitus (15).  
But in the present study, only pregnant women with a 
pre-pregnancy BMI of 19-25 kg/m
2
 were included in the 
study. Second, Louie et al. also included pregnant women 
with a history of gestational diabetes. The history of 
gestational diabetes is a known risk factor in the incidence of 
gestational diabetes (16). In the current study, the pregnant 
women participated in the study did not mention any history 
of gestational diabetes. Third, in the study by Louie et al., 
Cox's model was used to examine the effect of diet types on 
the incidence of gestational diabetes over time and the 
duration of the intervention was six months (the first and 
second trimester). In the present study, a regression model 
was used to evaluate the effect of trans-fatty acids on 
gestational diabetes mellitus and the duration of intervention 
was at least eight months. 
Studies have revealed contradictory results regarding the 
effects of trans-fatty acids on insulin resistance. The 
difference in the results may be due to the difference in the 
population studied or the difference in the time duration of 
receiving trans-fatty acids or the difference in the type of 
intervention and method of work. Some studies indicated the 
effect of trans-fatty acids on insulin resistance, some other 
studies pointed to the inability of these fats to affect insulin 
resistance (14, 17-18).  
Other studies have also suggested that trans-fatty acids 
may interfere with glucose metabolism and result in glucose 
tolerance disorder and insulin resistance; this condition in 
pregnancy is itself a diabetic condition that can increase the 
risk of gestational diabetes incidence (19-22). Therefore, 
further studies are needed to examine the effect of trans-fatty 
acids on insulin resistance and on the incidence of 
gestational diabetes (17, 20). 
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One of the strong points about the present study is the 
design of a unique diet for each pregnant woman, and the 
diet for each group was only different in pregnant women’s 
daily intake content of trans-fatty acids. Moreover, in the 
present study, a nutritional intervention and the diet were 
provided for the pregnant women at gestational age of 7 
weeks, and all pregnant women, along with the diet, were 
given an alternative list so that they could replace any item 
in the designed diet list that they were reluctant to use with a 
similar item on the alternative list that had the same 
nutritional value.  
Another strong point about this study was the supervision 
of the exact and accurate implementation of the diet designed 
for pregnant women at the end of each trimester via a 24-
hour dietary recall questionnaire. Furthermore, in the present 
study, we considered all the risk factors of gestational 
diabetes as exclusion criteria of the research units so that we 
can examine the effect of a diet with a trans-fatty acid 
content of less than 1% on the incidence of gestational 
diabetes. The sample size of the present study is sufficient 
and suitable enough to accurately and exactly evaluate the 
effect of trans-fatty acids on the risk of gestational diabetes 
mellitus. So far, no clinical trials have been conducted in 
Iran to evaluate the effect of daily intake of trans-fatty acids 
on the incidence of gestational diabetes.  
One of the limitations of this study is the lack of blood 
samples from pregnant women in order to assess the serum 
level of trans-fatty acids, however, in the present study, 24-
hour dietary recall questionnaire was used to evaluate trans-
fatty acid intake that it is adequate enough for the exact 
measurement of trans-fatty acid intake (23). 
Finally, this study showed that a diet with trans-fatty acid 
content of less than 1% could delay the incidence of 
gestational diabetes for 6 weeks that the same factor could 
reduce the risk of adverse effects such as polyhydramnios, 
macrosomia and consequently it reduces cesarean delivery. 
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